Compare JJSF & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JJSF | CERT |
|---|---|---|
| Founded | 1971 | 2008 |
| Country | United States | United States |
| Employees | 1800 | N/A |
| Industry | Specialty Foods | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.2B |
| IPO Year | 1995 | 2020 |
| Metric | JJSF | CERT |
|---|---|---|
| Price | $89.88 | $7.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $140.00 | $11.67 |
| AVG Volume (30 Days) | 230.3K | ★ 3.7M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.67% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ 1.99 | N/A |
| Revenue | ★ $1,022,038,000.00 | $418,838,000.00 |
| Revenue This Year | $0.30 | $4.18 |
| Revenue Next Year | $1.70 | $5.39 |
| P/E Ratio | $45.16 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $68.87 | $4.45 |
| 52 Week High | $114.06 | $13.88 |
| Indicator | JJSF | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 60.33 | 53.08 |
| Support Level | $88.35 | $7.94 |
| Resistance Level | $95.69 | $8.39 |
| Average True Range (ATR) | 2.50 | 0.29 |
| MACD | -0.22 | -0.07 |
| Stochastic Oscillator | 55.29 | 12.14 |
J&J Snack Foods Corp. manufactures snack foods and distributes frozen beverages, which it markets nationally to the foodservice and retail supermarket industries. The company's portfolio of frozen beverages, frozen novelties, and baked goods includes soft pretzels, frozen juice treats and desserts, stuffed sandwiches, churros, funnel cakes, cookies, and other snack foods and drinks. It operates through three segments: Food Service, which sells snacks, desserts, and baked goods at the point of sale; Retail Supermarkets, which sells frozen and prepackaged products to supermarkets; and Frozen Beverages, which sells frozen beverages under the ICEE, Slush Puppie, and Parrot Ice brands in the United States, Mexico, and Canada. The majority of revenue comes from the Food Service segment.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.